Form 4: Entera Bio Director Receives Stock Grant
Insider Transaction (Form 4)
Steven D Rubin, a Director of Entera Bio Ltd., reported multiple transactions in common stock on August 7, 2026.
Summary
- Grant/award: acquired 19,117 Ordinary Shares, par value NIS 0.0000769 per share on August 7, 2026; holds 34,117 after (Direct).
- Grant/award: acquired 33,368 Stock Option (right to buy) on August 7, 2026; holds 33,368 after (Direct).
- Grant/award: acquired 43,405 Stock Option (right to buy) on August 7, 2026; holds 43,405 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Steven D Rubin — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-07 | Grant/award | Ordinary Shares, par value NIS 0.0000769 per share | 19,117 | — | — | 34,117 |
| 2026-08-07 | Grant/award | Stock Option (right to buy) | 33,368 | — | — | 33,368 |
| 2026-08-07 | Grant/award | Stock Option (right to buy) | 43,405 | — | — | 43,405 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-07 | Grant/award (19,117 shares) |
| 2026-08-07 | Grant/award (33,368 shares) |
| 2026-08-07 | Grant/award (43,405 shares) |
Keywords
insider transaction, Form 4, [ENTX], Entera Bio Ltd., neutral, Steven D Rubin
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.